Ghazi Kashmolah is VP at Lucira Health, Inc. (LHDX). They have made 7 open-market trades across 1 company since 2022, most recently 2023-02-16.
CIK 0001877741
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| LHDX | 134,075 | $61K |
Shares reported on the most recent Form 4, priced at the 2023-02-21 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| LHDX | SELL | 2023-02-16 | 2023-02-21 | $0.27 | $1K | +138.1% | N/A | N/A |
| LHDX | SELL | 2022-11-28 | 2022-12-09 | $0.42 | $3K | -53.7% | +30.3% | N/A |
| LHDX | SELL | 2022-11-17 | 2022-12-09 | $0.37 | $12K | -53.7% | +30.3% | N/A |
| LHDX | SELL | 2022-11-16 | 2022-11-18 | $0.35 | $2K | -9.9% | -55.1% | -34.0% |
| LHDX | SELL | 2022-08-25 | 2022-08-29 | $1.93 | $3K | +0.6% | -36.3% | -77.7% |
| LHDX | SELL | 2022-08-17 | 2022-08-19 | $2.78 | $116K | -17.7% | -34.4% | -81.4% |
| LHDX | SELL | 2022-08-17 | 2022-08-24 | $2.52 | $48K | -13.6% | -35.9% | -75.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.